RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Piletz to Idazoxan

This is a "connection" page, showing publications John Piletz has written about Idazoxan.
Connection Strength

0.153
  1. Piletz JE, Ivanov TR, Sharp JD, Ernsberger P, Chang CH, Pickard RT, Gold G, Roth B, Zhu H, Jones JC, Baldwin J, Reis DJ. Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell Biol. 2000 Jun; 19(6):319-29.
    View in: PubMed
    Score: 0.047
  2. Ivanov TR, Feng Y, Wang H, Regunathan S, Reis DJ, Chikkala DN, Gupta P, Jones JC, Piletz JE. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists. J Psychiatr Res. 1998 Mar-Apr; 32(2):65-79.
    View in: PubMed
    Score: 0.040
  3. Zhu H, Paul IA, McNamara M, Redmond A, Nowak G, Piletz JE. Chronic imipramine treatment upregulates IR2-imidazoline receptive sites in rat brain. Neurochem Int. 1997 Jan; 30(1):101-7.
    View in: PubMed
    Score: 0.037
  4. Piletz JE, Sletten K. Nonadrenergic imidazoline binding sites on human platelets. J Pharmacol Exp Ther. 1993 Dec; 267(3):1493-502.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support